SlideShare una empresa de Scribd logo
1 de 24
ELISA
Presenter: Dr Pranav Sopory
Junior Resident
Dept. of Pharmacology
All India Institute of Medical Sciences
New Delhi
Mob: 9999-491-690
Email: pranav.sopory@gmail.com
Contents
Antigen-Antibody Reactions
Introduction to ELISA
Non-competitive ELISA
Reporting
Antibody
Produced by:
B cells Plasma Cells Antibody
Chromosome:
2 Heavy Chains - Chrm. 14
2 Light Chains - Chrm. 2 (ϰ)
Chrm. 22 (λ)
Disulfide bonds
Fab region:
Fragment antigen-binding
Variable region
Paratope binds to Epitope (Ag)
Fc region:
Fragment crystallizable region
Interacts with - cell surface (Fc receptor)
- complement system
Activates the immune system
Fab region
Fc region
Antigen – Antibody Reaction
• General Features
1. Specific, but specificity is not absolute!
2. Requires
a. Specific pH
b. Correct temperature
c. Electrolyte balance
3. Bonds involved
a. Van der waal
b. Hydrogen
c. Ionic
4. Combination: firm and reversible
Types of Ag-Ab reactions
Sensitive for Ag
Soluble Ag
+
Ab
+
Electrolyte
=
PRECIPITATION
Particulate Ag
+
Ab
+
Electrolyte
=
AGGLUTINATION
Sensitive for Ab
ELISA
• Enzyme Linked Immunosorbent Assay
1. Plate based Immunoassay
2. Works on the principle of Ag-Ab binding
3. Based on enzymatic-color reaction
4. Detects and quantifies substances such as peptides, proteins, hormones and
antibodies.
5. Types of ELISA
a. Qualitative: Positive or negative results
b. Quantitative: Optical density interpolated into a standard curve, which is
typically a serial dilution of the target
Immunoassay History
Before 1970s:
Radioimmunoassay: Used radioactively-labeled antigens or antibodies.
Was the only test available.
Radioactivity provides signal indicating presence of Ag or Ab.
Radioactivity poses a health risk to the technician.
1971:
Peter Perlmann and Eva Engvall at Stockholm University invented ELISA
1986: Generation of the first monoclonal antibodies (George Kohler and Cesar Milstein)
Specimen sample for ELISA
Serum HIV
CSF Neurocysticercosis
Sputum Brucellosis
Urine Legionnaire’s disease
Stool Giardiasis
Microtiter Well
Characteristics:
1. Marked on top: Numerically
2. Marked on the side: Alphabetically
3. Generally: 96 wells
Indirect ELISA
Enzyme cleaves substrate to produce color
Add Substrate (chromogen) for the Enzyme
Wash – To remove unbound secondary Ab
Add secondary Ab (Enzyme Linked)
Wash – To remove unbound Antibodies
Add Serum (contains primary Ab)
Microtiter well coated with Antigen
Indirect ELISA
• The indirect ELISA detects the presence of antibody in a sample
• Advantages:
1. Wide variety of Enzyme linked secondary antibodies available
2. Versatile: many primary antibodies can be made in one species and the
same labeled secondary antibody can be used for detection.
3. Increased sensitivity: each primary antibody contains several epitopes that
can be bound by the labeled secondary antibody, allowing for signal
amplification.
• Disadvantages:
1. Cross-reactivity: might occur with the secondary antibody, resulting in nonspecific signal.
2. An extra incubation step is required in the procedure. (compared to Direct ELISA)
ELISA: materials required
1. Testing Sample
2. Antibody (1st and 2nd)/ Antigen
3. Microtiter well
4. Blocking Buffer
5. Washing Buffer
6. Substrate
Nomenclature
EL: The second antibody is attached to an enzyme (‘enzyme-linked’)
I: Antigen is recognized by specific antibody (‘immuno’)
S: Antigen of interest is absorbed on to plastic surface (‘sorbent’)
A: Substrate reacts with enzyme to produce a product, usually colored,
which can be assessed (‘assay’)
Direct ELISA
Enzyme cleaves substrate to produce color
Add Substrate (chromogen) for the Enzyme
Wash – To remove unbound Antibodies
Add Serum (contains primary Ab that is Enzyme Linked)
Microtiter well coated with Antigen
Direct ELISA
• The direct ELISA detects the presence of antigen in a sample
• Advantages:
1. Quick methodology since only one antigen is used
2. Cross reactivity of second antibody is eliminated
• Disadvantages:
1. Immunoreactivity of primary antibody is reduced because its enzyme linked
2. Lesser signal amplification than Indirect ELISA
Sandwich ELISA
Enzyme cleaves substrate to produce color
Add Substrate (chromogen) for the Enzyme
Add Enzyme linked Antibody
Wash – To remove unbound Antibodies
Add serum (contains Ag to be detected)
Microtiter well coated with Capture Antibody
Sandwich ELISA
• The sandwich ELISA detects the presence of antigen in a sample
• Advantages:
1. High specificity because the antigen is specifically captured and detected.
2. Suitable for crude/impure samples as the antigen does not require purification
prior to measurement.
3. Flexible and sensitive, both direct or indirect detection methods can be used.
Buffers
Blocking protein
• a.k.a. “Detergent”
• Prevents other proteins from adsorbing to the
plate.
• Non-reactive protein like
1. Bovine Serum Albumin
Washing
• Necessary to remove non-bound reagents
• E.g.
• 1. Phosphate-buffered solution (PBS)
• 2. Tris – buffered saline (TBS)
Enzymes used in ELISA
Enzyme Substrate Chromogen
Horseradish Peroxidase
(M/C)
H2O2 Tetra methyl benzidine
(TMB)
Alkaline Phosphatase Nitrophenyl Phosphate
(NPP)
Diethandamine + MgCl2
Results
• Absorbance from Microtiter wells detected via Microplate readers
Final plate of ELISA Microplate reader
Results
Source
Lens
Filter
MTP
Detector Calculation
REPORT
Calculation
• Data graphed between Optical density Vs Log concentration.
• Known conc. of Ag are used to produce a standard curve.
• This data is used to measure the conc. of unknown samples by
comparison to the linear portion of the standard curve.
Conc. of substance (pg/ml)
OpticalDensity
22
ELISA
Advantages
• Long shelf life
• Easy to perform
• Quick
• Widely available
Disadvantages
• Enzyme activity maybe
affected by plasma
constituents
• Expensive
Limitations
• Results may not be
absolute
• Ab may be not available
• False positives/negatives
(mutated antigen)
Thank You

Más contenido relacionado

La actualidad más candente

Homogeneous and heterogeneous immunoassay
Homogeneous and heterogeneous immunoassayHomogeneous and heterogeneous immunoassay
Homogeneous and heterogeneous immunoassaykamrudeen samani
 
RIA, IMMUNOFLURESCENCE ASSAY
RIA, IMMUNOFLURESCENCE ASSAYRIA, IMMUNOFLURESCENCE ASSAY
RIA, IMMUNOFLURESCENCE ASSAYSKYFALL
 
Presentation of elisa test
Presentation of elisa testPresentation of elisa test
Presentation of elisa testMuhammad iqbal
 
Enzyme linked immunosorbent assay (elisa)
Enzyme linked immunosorbent assay (elisa)Enzyme linked immunosorbent assay (elisa)
Enzyme linked immunosorbent assay (elisa)Naima Qureshi
 
Complement fixation test (CFT)
Complement fixation test (CFT)Complement fixation test (CFT)
Complement fixation test (CFT)Saranraj P
 
Serological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious DiseasesSerological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious DiseasesMostafa Mahmoud
 
Antigen antibody reactions
Antigen antibody reactionsAntigen antibody reactions
Antigen antibody reactionsDr. Armaan Singh
 
Immunoprecipitation Presentation
Immunoprecipitation PresentationImmunoprecipitation Presentation
Immunoprecipitation PresentationVibhutiSardana1
 
antigen antibody interaction
antigen antibody interactionantigen antibody interaction
antigen antibody interactionArunima Sur
 
Fluoro immunoassay ppt
Fluoro immunoassay pptFluoro immunoassay ppt
Fluoro immunoassay pptSkAzizuddin1
 
Enzyme linked immunosorbent assay
Enzyme linked immunosorbent assayEnzyme linked immunosorbent assay
Enzyme linked immunosorbent assayIqra Rana
 
Enzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significanceEnzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significancerohini sane
 

La actualidad más candente (20)

Radioimmunoassay
RadioimmunoassayRadioimmunoassay
Radioimmunoassay
 
Homogeneous and heterogeneous immunoassay
Homogeneous and heterogeneous immunoassayHomogeneous and heterogeneous immunoassay
Homogeneous and heterogeneous immunoassay
 
RIA
RIARIA
RIA
 
Enzyme immunoassays
Enzyme immunoassaysEnzyme immunoassays
Enzyme immunoassays
 
Elisa
Elisa Elisa
Elisa
 
RIA, IMMUNOFLURESCENCE ASSAY
RIA, IMMUNOFLURESCENCE ASSAYRIA, IMMUNOFLURESCENCE ASSAY
RIA, IMMUNOFLURESCENCE ASSAY
 
ELISA
ELISAELISA
ELISA
 
Presentation of elisa test
Presentation of elisa testPresentation of elisa test
Presentation of elisa test
 
Enzyme linked immunosorbent assay (elisa)
Enzyme linked immunosorbent assay (elisa)Enzyme linked immunosorbent assay (elisa)
Enzyme linked immunosorbent assay (elisa)
 
Elisa ppt
Elisa pptElisa ppt
Elisa ppt
 
Radio Immunoassay Notes
Radio Immunoassay NotesRadio Immunoassay Notes
Radio Immunoassay Notes
 
Complement fixation test (CFT)
Complement fixation test (CFT)Complement fixation test (CFT)
Complement fixation test (CFT)
 
Serological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious DiseasesSerological Diagnosis of Infectious Diseases
Serological Diagnosis of Infectious Diseases
 
Complement fixation tests
Complement fixation testsComplement fixation tests
Complement fixation tests
 
Antigen antibody reactions
Antigen antibody reactionsAntigen antibody reactions
Antigen antibody reactions
 
Immunoprecipitation Presentation
Immunoprecipitation PresentationImmunoprecipitation Presentation
Immunoprecipitation Presentation
 
antigen antibody interaction
antigen antibody interactionantigen antibody interaction
antigen antibody interaction
 
Fluoro immunoassay ppt
Fluoro immunoassay pptFluoro immunoassay ppt
Fluoro immunoassay ppt
 
Enzyme linked immunosorbent assay
Enzyme linked immunosorbent assayEnzyme linked immunosorbent assay
Enzyme linked immunosorbent assay
 
Enzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significanceEnzyme linked immunosorbent assay (elisa) and its clinical significance
Enzyme linked immunosorbent assay (elisa) and its clinical significance
 

Similar a ELISA

Enzyme Linked Immunosorbent Assay (ELISA)
Enzyme Linked Immunosorbent Assay (ELISA)Enzyme Linked Immunosorbent Assay (ELISA)
Enzyme Linked Immunosorbent Assay (ELISA)Harshjoshi108
 
Enzyme linked immuno sorbent assay (elisa)
Enzyme linked immuno sorbent assay (elisa)Enzyme linked immuno sorbent assay (elisa)
Enzyme linked immuno sorbent assay (elisa)replisome
 
ELISA_AI_15092023.pptx
ELISA_AI_15092023.pptxELISA_AI_15092023.pptx
ELISA_AI_15092023.pptxnurulvu
 
ELISA Principle, How it works
ELISA Principle, How it works ELISA Principle, How it works
ELISA Principle, How it works James Waita
 
Enzyme-Linked Immunosorbent Assay.pptx
Enzyme-Linked Immunosorbent Assay.pptxEnzyme-Linked Immunosorbent Assay.pptx
Enzyme-Linked Immunosorbent Assay.pptxnedalalazzwy
 
ELISA Powerpoint Presentation
ELISA Powerpoint PresentationELISA Powerpoint Presentation
ELISA Powerpoint PresentationAnita Singh
 
Labeled antibody techniques , ELISA
Labeled antibody techniques , ELISA Labeled antibody techniques , ELISA
Labeled antibody techniques , ELISA Amany Elsayed
 
Enzyme linked immunosorbant assay
Enzyme linked immunosorbant assayEnzyme linked immunosorbant assay
Enzyme linked immunosorbant assayKavyaRojesh
 
principle instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresisprinciple instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresisAnimikh Ray
 
ALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptx
ALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptxALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptx
ALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptxJOPHUONG
 
ELISA- Principle, Types and Applications.pptx
ELISA- Principle, Types and Applications.pptxELISA- Principle, Types and Applications.pptx
ELISA- Principle, Types and Applications.pptxAmit kumar Singh
 

Similar a ELISA (20)

Elisa ppt
Elisa pptElisa ppt
Elisa ppt
 
ELISA
ELISAELISA
ELISA
 
Enzyme Linked Immunosorbent Assay (ELISA)
Enzyme Linked Immunosorbent Assay (ELISA)Enzyme Linked Immunosorbent Assay (ELISA)
Enzyme Linked Immunosorbent Assay (ELISA)
 
ELISA.pptx
ELISA.pptxELISA.pptx
ELISA.pptx
 
Enzyme linked immuno sorbent assay (elisa)
Enzyme linked immuno sorbent assay (elisa)Enzyme linked immuno sorbent assay (elisa)
Enzyme linked immuno sorbent assay (elisa)
 
ELISA_AI_15092023.pptx
ELISA_AI_15092023.pptxELISA_AI_15092023.pptx
ELISA_AI_15092023.pptx
 
ELISA Principle, How it works
ELISA Principle, How it works ELISA Principle, How it works
ELISA Principle, How it works
 
ELISA Principle
ELISA PrincipleELISA Principle
ELISA Principle
 
Elisa seminar final2
Elisa seminar final2Elisa seminar final2
Elisa seminar final2
 
Enzyme-Linked Immunosorbent Assay.pptx
Enzyme-Linked Immunosorbent Assay.pptxEnzyme-Linked Immunosorbent Assay.pptx
Enzyme-Linked Immunosorbent Assay.pptx
 
ELISA Presentation.ppt
ELISA Presentation.pptELISA Presentation.ppt
ELISA Presentation.ppt
 
Elisa
Elisa Elisa
Elisa
 
ELISA Powerpoint Presentation
ELISA Powerpoint PresentationELISA Powerpoint Presentation
ELISA Powerpoint Presentation
 
Labeled antibody techniques , ELISA
Labeled antibody techniques , ELISA Labeled antibody techniques , ELISA
Labeled antibody techniques , ELISA
 
Enzyme linked immunosorbant assay
Enzyme linked immunosorbant assayEnzyme linked immunosorbant assay
Enzyme linked immunosorbant assay
 
Elisa
Elisa Elisa
Elisa
 
Elisa
ElisaElisa
Elisa
 
principle instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresisprinciple instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresis
 
ALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptx
ALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptxALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptx
ALISATechnique-Principles-Types-HowCanMakeKittoDetermineAnyBiomarker.pptx
 
ELISA- Principle, Types and Applications.pptx
ELISA- Principle, Types and Applications.pptxELISA- Principle, Types and Applications.pptx
ELISA- Principle, Types and Applications.pptx
 

Más de Pranav Sopory

Schizophrenia and Psychosis: Antipsychotics
Schizophrenia and Psychosis: AntipsychoticsSchizophrenia and Psychosis: Antipsychotics
Schizophrenia and Psychosis: AntipsychoticsPranav Sopory
 
GOLD (COPD) & GINA (Asthma) guidelines: 2018 update
GOLD (COPD) & GINA (Asthma) guidelines: 2018 updateGOLD (COPD) & GINA (Asthma) guidelines: 2018 update
GOLD (COPD) & GINA (Asthma) guidelines: 2018 updatePranav Sopory
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesPranav Sopory
 
Cancer Immunotherapy
Cancer ImmunotherapyCancer Immunotherapy
Cancer ImmunotherapyPranav Sopory
 
JNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of HypertensionJNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of HypertensionPranav Sopory
 
Tauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsTauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsPranav Sopory
 
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.Pranav Sopory
 
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...Pranav Sopory
 
Animal Models for Seizure and Epilepsy
Animal Models for Seizure and EpilepsyAnimal Models for Seizure and Epilepsy
Animal Models for Seizure and EpilepsyPranav Sopory
 
Antibody drug conjugates current status and future perspectives
Antibody drug conjugates  current status and future perspectivesAntibody drug conjugates  current status and future perspectives
Antibody drug conjugates current status and future perspectivesPranav Sopory
 
Hematological toxicities of anticancer agents (management strategies)
Hematological toxicities of anticancer agents (management strategies)Hematological toxicities of anticancer agents (management strategies)
Hematological toxicities of anticancer agents (management strategies)Pranav Sopory
 
Preclinial Screening methods for Kala Azar
Preclinial Screening methods for Kala AzarPreclinial Screening methods for Kala Azar
Preclinial Screening methods for Kala AzarPranav Sopory
 
Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)Pranav Sopory
 

Más de Pranav Sopory (14)

Schizophrenia and Psychosis: Antipsychotics
Schizophrenia and Psychosis: AntipsychoticsSchizophrenia and Psychosis: Antipsychotics
Schizophrenia and Psychosis: Antipsychotics
 
GOLD (COPD) & GINA (Asthma) guidelines: 2018 update
GOLD (COPD) & GINA (Asthma) guidelines: 2018 updateGOLD (COPD) & GINA (Asthma) guidelines: 2018 update
GOLD (COPD) & GINA (Asthma) guidelines: 2018 update
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
 
Cancer Immunotherapy
Cancer ImmunotherapyCancer Immunotherapy
Cancer Immunotherapy
 
JNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of HypertensionJNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of Hypertension
 
Tauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsTauopathy and its therapeutic targets
Tauopathy and its therapeutic targets
 
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.
 
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
Genetic and epigenetic biomarkers for therapeutic monitoring in neurological ...
 
Animal Models for Seizure and Epilepsy
Animal Models for Seizure and EpilepsyAnimal Models for Seizure and Epilepsy
Animal Models for Seizure and Epilepsy
 
Antibody drug conjugates current status and future perspectives
Antibody drug conjugates  current status and future perspectivesAntibody drug conjugates  current status and future perspectives
Antibody drug conjugates current status and future perspectives
 
HPLC- Lite
HPLC- LiteHPLC- Lite
HPLC- Lite
 
Hematological toxicities of anticancer agents (management strategies)
Hematological toxicities of anticancer agents (management strategies)Hematological toxicities of anticancer agents (management strategies)
Hematological toxicities of anticancer agents (management strategies)
 
Preclinial Screening methods for Kala Azar
Preclinial Screening methods for Kala AzarPreclinial Screening methods for Kala Azar
Preclinial Screening methods for Kala Azar
 
Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)
 

Último

Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Dr. David Greene Arizona
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfAditiAlishetty
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfDharma Homoeopathy
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationpratiksha ghimire
 
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSSARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSNehaSaini499770
 
Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...amynickle2106
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingNursing education
 
ILO (International Labour Organization )
ILO (International Labour Organization )ILO (International Labour Organization )
ILO (International Labour Organization )Puja Kumari
 
arpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationarpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationNursing education
 
What are weight loss medication services?
What are weight loss medication services?What are weight loss medication services?
What are weight loss medication services?Optimal Healing 4u
 
Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfMohamed Miyir
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
Artificial Intelligence Robotics & Computational Fluid Dynamics
Artificial Intelligence Robotics & Computational Fluid DynamicsArtificial Intelligence Robotics & Computational Fluid Dynamics
Artificial Intelligence Robotics & Computational Fluid DynamicsParag Kothawade
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfSasikiranMarri
 
Mental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health studentsMental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health studentseyobkaseye
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology InsightsHealth Catalyst
 
unit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxunit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxBkGupta21
 

Último (20)

Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
 
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdfDr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentation
 
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSSARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
 
Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...
 
Kidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani HospitalKidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani Hospital
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursing
 
ILO (International Labour Organization )
ILO (International Labour Organization )ILO (International Labour Organization )
ILO (International Labour Organization )
 
arpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationarpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and education
 
What are weight loss medication services?
What are weight loss medication services?What are weight loss medication services?
What are weight loss medication services?
 
Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdf
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
Artificial Intelligence Robotics & Computational Fluid Dynamics
Artificial Intelligence Robotics & Computational Fluid DynamicsArtificial Intelligence Robotics & Computational Fluid Dynamics
Artificial Intelligence Robotics & Computational Fluid Dynamics
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
 
Mental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health studentsMental Health for physiotherapy and other health students
Mental Health for physiotherapy and other health students
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights
 
unit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxunit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptx
 

ELISA

  • 1. ELISA Presenter: Dr Pranav Sopory Junior Resident Dept. of Pharmacology All India Institute of Medical Sciences New Delhi Mob: 9999-491-690 Email: pranav.sopory@gmail.com
  • 2. Contents Antigen-Antibody Reactions Introduction to ELISA Non-competitive ELISA Reporting
  • 3. Antibody Produced by: B cells Plasma Cells Antibody Chromosome: 2 Heavy Chains - Chrm. 14 2 Light Chains - Chrm. 2 (ϰ) Chrm. 22 (λ) Disulfide bonds Fab region: Fragment antigen-binding Variable region Paratope binds to Epitope (Ag) Fc region: Fragment crystallizable region Interacts with - cell surface (Fc receptor) - complement system Activates the immune system Fab region Fc region
  • 4. Antigen – Antibody Reaction • General Features 1. Specific, but specificity is not absolute! 2. Requires a. Specific pH b. Correct temperature c. Electrolyte balance 3. Bonds involved a. Van der waal b. Hydrogen c. Ionic 4. Combination: firm and reversible
  • 5. Types of Ag-Ab reactions Sensitive for Ag Soluble Ag + Ab + Electrolyte = PRECIPITATION Particulate Ag + Ab + Electrolyte = AGGLUTINATION Sensitive for Ab
  • 6. ELISA • Enzyme Linked Immunosorbent Assay 1. Plate based Immunoassay 2. Works on the principle of Ag-Ab binding 3. Based on enzymatic-color reaction 4. Detects and quantifies substances such as peptides, proteins, hormones and antibodies. 5. Types of ELISA a. Qualitative: Positive or negative results b. Quantitative: Optical density interpolated into a standard curve, which is typically a serial dilution of the target
  • 7. Immunoassay History Before 1970s: Radioimmunoassay: Used radioactively-labeled antigens or antibodies. Was the only test available. Radioactivity provides signal indicating presence of Ag or Ab. Radioactivity poses a health risk to the technician. 1971: Peter Perlmann and Eva Engvall at Stockholm University invented ELISA 1986: Generation of the first monoclonal antibodies (George Kohler and Cesar Milstein)
  • 8. Specimen sample for ELISA Serum HIV CSF Neurocysticercosis Sputum Brucellosis Urine Legionnaire’s disease Stool Giardiasis
  • 9. Microtiter Well Characteristics: 1. Marked on top: Numerically 2. Marked on the side: Alphabetically 3. Generally: 96 wells
  • 10. Indirect ELISA Enzyme cleaves substrate to produce color Add Substrate (chromogen) for the Enzyme Wash – To remove unbound secondary Ab Add secondary Ab (Enzyme Linked) Wash – To remove unbound Antibodies Add Serum (contains primary Ab) Microtiter well coated with Antigen
  • 11. Indirect ELISA • The indirect ELISA detects the presence of antibody in a sample • Advantages: 1. Wide variety of Enzyme linked secondary antibodies available 2. Versatile: many primary antibodies can be made in one species and the same labeled secondary antibody can be used for detection. 3. Increased sensitivity: each primary antibody contains several epitopes that can be bound by the labeled secondary antibody, allowing for signal amplification. • Disadvantages: 1. Cross-reactivity: might occur with the secondary antibody, resulting in nonspecific signal. 2. An extra incubation step is required in the procedure. (compared to Direct ELISA)
  • 12. ELISA: materials required 1. Testing Sample 2. Antibody (1st and 2nd)/ Antigen 3. Microtiter well 4. Blocking Buffer 5. Washing Buffer 6. Substrate
  • 13. Nomenclature EL: The second antibody is attached to an enzyme (‘enzyme-linked’) I: Antigen is recognized by specific antibody (‘immuno’) S: Antigen of interest is absorbed on to plastic surface (‘sorbent’) A: Substrate reacts with enzyme to produce a product, usually colored, which can be assessed (‘assay’)
  • 14. Direct ELISA Enzyme cleaves substrate to produce color Add Substrate (chromogen) for the Enzyme Wash – To remove unbound Antibodies Add Serum (contains primary Ab that is Enzyme Linked) Microtiter well coated with Antigen
  • 15. Direct ELISA • The direct ELISA detects the presence of antigen in a sample • Advantages: 1. Quick methodology since only one antigen is used 2. Cross reactivity of second antibody is eliminated • Disadvantages: 1. Immunoreactivity of primary antibody is reduced because its enzyme linked 2. Lesser signal amplification than Indirect ELISA
  • 16. Sandwich ELISA Enzyme cleaves substrate to produce color Add Substrate (chromogen) for the Enzyme Add Enzyme linked Antibody Wash – To remove unbound Antibodies Add serum (contains Ag to be detected) Microtiter well coated with Capture Antibody
  • 17. Sandwich ELISA • The sandwich ELISA detects the presence of antigen in a sample • Advantages: 1. High specificity because the antigen is specifically captured and detected. 2. Suitable for crude/impure samples as the antigen does not require purification prior to measurement. 3. Flexible and sensitive, both direct or indirect detection methods can be used.
  • 18. Buffers Blocking protein • a.k.a. “Detergent” • Prevents other proteins from adsorbing to the plate. • Non-reactive protein like 1. Bovine Serum Albumin Washing • Necessary to remove non-bound reagents • E.g. • 1. Phosphate-buffered solution (PBS) • 2. Tris – buffered saline (TBS)
  • 19. Enzymes used in ELISA Enzyme Substrate Chromogen Horseradish Peroxidase (M/C) H2O2 Tetra methyl benzidine (TMB) Alkaline Phosphatase Nitrophenyl Phosphate (NPP) Diethandamine + MgCl2
  • 20. Results • Absorbance from Microtiter wells detected via Microplate readers Final plate of ELISA Microplate reader
  • 22. Calculation • Data graphed between Optical density Vs Log concentration. • Known conc. of Ag are used to produce a standard curve. • This data is used to measure the conc. of unknown samples by comparison to the linear portion of the standard curve. Conc. of substance (pg/ml) OpticalDensity 22
  • 23. ELISA Advantages • Long shelf life • Easy to perform • Quick • Widely available Disadvantages • Enzyme activity maybe affected by plasma constituents • Expensive Limitations • Results may not be absolute • Ab may be not available • False positives/negatives (mutated antigen)

Notas del editor

  1. https://www.thermofisher.com/in/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-elisa.html
  2. a measure of the capacity of a substance to absorb light of a specified wavelength. It is equal to the logarithm of the reciprocal of the transmittance.